TTrialPathMatch Me to Trials
← Back to trials
RecruitingDepressive SymptomsDepressionAnxiety

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Eligible age

18–50 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

Sponsor: Universidade do Sul de Santa Catarina

You may qualify if…

  • ✓ Age between 18 and 50 years old
  • ✓ PHQ-9 score between 10 and 19 (moderate depression)
  • ✓ Availability for sessions

You may not qualify if…

  • ✕ Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy

Source: ClinicalTrials.gov · NCT05855421 · last updated 2025-01-20

Efficacy and Safety of Auricular Acupuncture in Depression During the · TrialPath